Incio et al. provided evidence of the direct impact of desmoplasia on the neoplastic process in pancreatic cancer and showed that ACE inhibitors can improve treatment outcomes (Incio et al. 2016). The gene discussed is ACE; the disease is familial pancreatic carcinoma.